Barrow Hanley Mewhinney & Strauss LLC / MRK
Barrow Hanley Mewhinney & Strauss LLC’s Merck & Co Inc Position
Does Barrow Hanley Mewhinney & Strauss LLC own Merck & Co Inc (MRK)? Yes — 7.92M shares worth $952M (+3.12% of its 13F portfolio) as of Q1 2026, up from 7.79M shares the prior filed quarter.
Position Value
$952M
Q1 2026
Shares
7.92M
% of Portfolio
+3.12%
Quarters Held
30
currently held
Position History MRK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 7.92M | $952M | +3.12% |
| Q4 2025 | 7.79M | $820M | +2.73% |
| Q3 2025 | 7.42M | $622M | +1.98% |
| Q2 2025 | 8.71M | $689M | +2.32% |
| Q1 2025 | 7.79M | $699M | +2.54% |
| Q4 2024 | 6.29M | $625M | +2.13% |
| Q3 2024 | 5.66M | $642M | +2.10% |
| Q2 2024 | 5.89M | $729M | +2.49% |
| Q1 2024 | 6.18M | $816M | +2.75% |
| Q4 2023 | 6.54M | $713M | +2.51% |
| Q3 2023 | 6.54M | $673M | +2.57% |
| Q2 2023 | 6.61M | $763M | +2.84% |
| Q1 2023 | 8.19M | $872M | +3.37% |
| Q4 2022 | 9.45M | $1.0B | +3.94% |
| Q3 2022 | 10.14M | $873M | +3.58% |
| Q2 2022 | 10.93M | $996M | +3.76% |
| Q1 2022 | 11.06M | $908M | +2.96% |
| Q4 2021 | 10.47M | $803M | +2.54% |
| Q3 2021 | 10.21M | $767M | +2.54% |
| Q2 2021 | 10.15M | $789M | +2.53% |
| Q1 2021 | 712.3K | $55M | +0.17% |
| Q4 2020 | 40.0K | $3M | +0.01% |
| Q3 2020 | 40.5K | $3M | +0.01% |
| Q2 2020 | 65.5K | $5M | +0.02% |
| Q1 2020 | 65.5K | $5M | +0.02% |
| Q4 2019 | 65.5K | $6M | +0.02% |
| Q3 2019 | 641.0K | $54M | +0.11% |
| Q2 2019 | 1.70M | $142M | +0.26% |
| Q1 2019 | 1.86M | $154M | +0.28% |
| Q4 2018 | 3.22M | $246M | +0.48% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Barrow Hanley Mewhinney & Strauss LLC’s full portfolio or all institutional holders of MRK.